Forty-one recent cases of invasive zygomycosis from a global clinical registry

Zygomycosis in Italy: A Survey of FIMUA-ECMM (Federazione Italiana Di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)

(2014) L. Pagano et al.   JOURNAL OF CHEMOTHERAPY

Fatal Rhizopus Pneumonia in Allogeneic Stem Cell Transplant Patients Despite Posaconazole Prophylaxis: Two Cases and Review of the Literature

(2009) Lazaros J. Lekakis et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Recent Advances in the Management of Mucormycosis: From Bench to Bedside

(2009) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis

(2008) A. S. Ibrahim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation

(2008) F Schlemmer et al.   BONE MARROW TRANSPLANTATION

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

(2008) Georgios Chamilos et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES

Comparativein vitroactivities of posaconazole, voriconazole, itraconazole, and amphotericin B againstAspergillusandRhizopus, and synergy testing forRhizopus

(2008) Sevtap Arikan et al.   MEDICAL MYCOLOGY

Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up

(2008) Joseph J Kishel et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE